Ferdows Atiq1, Eveline P Mauser-Bunschoten2, Jeroen Eikenboom3,4, Karin P M van Galen2, Karina Meijer5, Joke de Meris6, Marjon H Cnossen7, Erick A M Beckers8, Britta A P Laros-van Gorkom9, Laurens Nieuwenhuizen10, Johanna G van der Bom11,12, Karin Fijnvandraat13, Frank W G Leebeek1. 1. Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands. 2. Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. 3. Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands. 4. Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, Leiden, The Netherlands. 5. Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 6. Netherlands Hemophilia Patient Society, Leiden, The Netherlands. 7. Department of Pediatric Hematology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands. 8. Department of Internal Medicine, Maastricht University Medical Center Plus, Maastricht, The Netherlands. 9. Department of Hematology, Radboud university medical center, Nijmegen, The Netherlands. 10. Department of Internal Medicine, Maxima Medical Center, Eindhoven, The Netherlands. 11. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. 12. Jon J van Rood Center for Clinical Transfusion Medicine, Sanquin Research, Leiden, The Netherlands. 13. Pediatric Hematology, Emma Children's Hospital-Academic Medical Center, Amsterdam, The Netherlands.
Abstract
INTRODUCTION: Patients with bleeding disorders may experience limitations in sports participation and physical activity. Several studies on sports participation have been performed in haemophilia patients, but studies in patients with von Willebrand disease (VWD) are lacking. AIM: We assessed the sports participation and physical activity of a large cohort of VWD patients. METHODS: Patients were included from the "WiN study." All patients completed a questionnaire on sports participation, physical activity, quality of life and bleeding symptoms (Tosetto bleeding score). RESULTS: From the 798 included patients, 474 had type 1, 301 type 2 and 23 type 3 VWD. The mean age was 39 ± 20 (standard deviation) years. Five hundred and fifty-two patients (69.3%) participated in various types of sports. Type 3 VWD patients more often did not participate in sports due to fear of bleeding and physical impairment, respectively, OR = 13.24 (95% CI: 2.45-71.53) and OR = 5.90 (95% CI: 1.77-19.72). Patients who did not participate in sports due to physical impairment had a higher bleeding score item for joint bleeds 1.0 (±1.6) vs 0.5 (± 1.1) (P = 0.036). Patients with type 3 VWD and patients with a higher bleeding score frequently had severe limitations during daily activities, respectively, OR = 9.84 (95% CI: 2.83-34.24) and OR = 1.08 (95% CI: 1.04-1.12). CONCLUSION: The majority of VWD patients participated in sports. Patients with type 3 VWD, a history of joint bleeds and a more severe bleeding phenotype frequently experienced limitations in sports participation and physical activities during daily life.
INTRODUCTION:Patients with bleeding disorders may experience limitations in sports participation and physical activity. Several studies on sports participation have been performed in haemophiliapatients, but studies in patients with von Willebrand disease (VWD) are lacking. AIM: We assessed the sports participation and physical activity of a large cohort of VWDpatients. METHODS:Patients were included from the "WiN study." All patients completed a questionnaire on sports participation, physical activity, quality of life and bleeding symptoms (Tosetto bleeding score). RESULTS: From the 798 included patients, 474 had type 1, 301 type 2 and 23 type 3 VWD. The mean age was 39 ± 20 (standard deviation) years. Five hundred and fifty-two patients (69.3%) participated in various types of sports. Type 3 VWDpatients more often did not participate in sports due to fear of bleeding and physical impairment, respectively, OR = 13.24 (95% CI: 2.45-71.53) and OR = 5.90 (95% CI: 1.77-19.72). Patients who did not participate in sports due to physical impairment had a higher bleeding score item for joint bleeds 1.0 (±1.6) vs 0.5 (± 1.1) (P = 0.036). Patients with type 3 VWD and patients with a higher bleeding score frequently had severe limitations during daily activities, respectively, OR = 9.84 (95% CI: 2.83-34.24) and OR = 1.08 (95% CI: 1.04-1.12). CONCLUSION: The majority of VWDpatients participated in sports. Patients with type 3 VWD, a history of joint bleeds and a more severe bleeding phenotype frequently experienced limitations in sports participation and physical activities during daily life.
Authors: Nathan T Connell; Veronica H Flood; Romina Brignardello-Petersen; Rezan Abdul-Kadir; Alice Arapshian; Susie Couper; Jean M Grow; Peter Kouides; Michael Laffan; Michelle Lavin; Frank W G Leebeek; Sarah H O'Brien; Margareth C Ozelo; Alberto Tosetto; Angela C Weyand; Paula D James; Mohamad A Kalot; Nedaa Husainat; Reem A Mustafa Journal: Blood Adv Date: 2021-01-12
Authors: Ferdows Atiq; Lisette M Schütte; Agnes E M Looijen; Johan Boender; Marjon H Cnossen; Jeroen Eikenboom; Moniek P M de Maat; Marieke J H A Kruip; Frank W G Leebeek Journal: Blood Adv Date: 2019-12-23
Authors: F Atiq; J L Saes; M C Punt; K P M van Galen; R E G Schutgens; K Meijer; M H Cnossen; B A P Laros-Van Gorkom; M Peters; L Nieuwenhuizen; M J H A Kruip; J de Meris; J G van der Bom; F J M van der Meer; K Fijnvandraat; I C Kruis; W L van Heerde; H C J Eikenboom; Frank W G Leebeek; S E M Schols Journal: EClinicalMedicine Date: 2021-01-29
Authors: Eva K Kempers; Calvin B van Kwawegen; Joke de Meris; Saskia E M Schols; Karin P M van Galen; Karina Meijer; Marjon H Cnossen; Johanna G van der Bom; Karin Fijnvandraat; Jeroen Eikenboom; Ferdows Atiq; Frank W G Leebeek Journal: Haemophilia Date: 2021-12-29 Impact factor: 4.263
Authors: Evelien S van Hoorn; Maite E Houwing; Wala Al Arashi; Frank W G Leebeek; Jan A Hazelzet; Samantha C Gouw; Roger E G Schutgens; Saskia E M Schols; Hester F Lingsma; Marjon H Cnossen Journal: Haemophilia Date: 2022-01-18 Impact factor: 4.263